We can also deliver gentle electric pulses to the pain processing centers of the spinal cord to block or alter pain signals to the brain. Patients can trial this treatment, called neurostimulation, before deciding whether to have a permanent neurostimulator implanted. We consider this therapy to be a ‘pacemaker for the nervous system’ since the technology has evolved from cardiac pacemakers. Neurostimulation is especially effective for nerve pain caused by cancer treatments, such as radiation therapy and chemotherapy, and the permanent implant involves a minimally invasive 45-minute surgery done in an outpatient surgery center.
Targeted Drug Delivery (TDD), with pain-relieving medications delivered directly into the intrathecal space, is a powerful tool in the fight against cancer pain. Fully implanted pain pumps can deliver medications, such as opioids and local anesthetics, directly to the spinal nerves that transmit pain signals from invasive cancer to the brain. This allows for better pain control than systemic opioids with much less impact on cognition. If the pain pump is implanted in the early stages of cancer pain and treatment, the patient can recover quickly from the minor surgery associated with the implant and engage more effectively in therapy. TDD may also help patients hospitalized for cancer pain management be discharged from the hospital and managed at home. If a patient’s cancer pain resolves, the pain pump can easily be removed depending on the patient’s wishes. However, patients who recover from cancer often have persistent pain, and in such cases, the pain pump can be used to provide ongoing pain relief. We occasionally use the pain pump in addition to spinal cord stimulation to treat complex cancer pain, since both technologies block pain at the spinal cord level by different and synergistic mechanisms.
Educating patients and physicians
Nura's pain specialist physicians have been treating patients with cancer pain since the inception of our pain clinic in 1995, but referrals for cancer pain management have been few and far between. With advanced technology and our pain management expertise, we believe we can provide significant help to cancer pain patients and to the oncologists who care for them. Therefore, we are making a concerted effort to educate cancer patients and their managing physicians about cancer pain options, and we are available anytime for informal discussions. Our pain specialists are available to evaluate and treat cancer pain patients on an urgent basis, usually within 24 hours of referral, and our entire medical practice is committed to providing timely, effective and quality care to patients who are suffering from cancer-related pain.
R. Scott Stayner, MD, PhD,
is the Medical Director of Nura Ambulatory Surgery Centers. He is board certified in anesthesiology and pain management. He completed his anesthesiology residency at the University of Minnesota, his Fellowship in Pain Management with the University of California, Davis, and is a graduate of the University of Minnesota Medical School. He earned a PhD in Bioengineering from the University of Utah.
David Schultz, MD,
is the medical director and founder of Nura Pain Clinics. Dr. Schultz is a board-certified anesthesiologist with additional board certification in pain medicine from the American Board of Anesthesiology, the American Board of Interventional Pain Physicians, and the American Board of Pain Medicine. He has been a full-time interventional pain specialist since 1995.